Internet Live Events
Transparency on trial
Merck & Co
Johnson & Johnson
Analytical testing, QC
Contract sales & marketing
Drug delivery, formulation
Fill & finish, packaging
Supply chain, logistics
Videos & Audio
Shows & Conferences
GPCM 2014 London
PCT 2013 Vienna
Patient Recruitment Outsourcing 2011
The scale of the global cancer challenge
News from DIA 2011
News from AAPS 2010
One should not forget that CROs still work for sponsors and do not conduct trials for themselves. The fact that sales outside the US have grown that much demonstrates that the big pharma , which is by far the biggest client of global CROs, is more and more interested in selling its products outside the US market. This is particularly true for emerging countries such as Brasil or India. And since it is way easier to get registration and to sell its drug, in Brasil for example, once trials have been conducted in the country, sponsors ask for CROs to have an international expansion. Therefore it is not only the CROs that are globalising, it is the whole pharma industry.
Posted by Guillaume Miara30 August 2011 | 15h30
Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.
We will not publish your email on the site
Back to: Over 50% of sales at top CROs now made outside US; report
Access all events listing
Our events, Shows & Conferences...
Subscribe to our FREE newsletterSUBSCRIBE
Global Pharmaceutical Technology & Manufacturing
Biopharmaceutical Development & Manufacturing
About us | Site map |
© William Reed Business Media SAS 2015, All rights reserved.